Boxer Capital Management’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
AG
Boxer Capital Management's GOSS Position: Q4 2023 in Review
Boxer Capital Management sold out of Gossamer Bio (GOSS) in Q4 2023, closing a stake of 81,221 shares — an estimated $5.41M sold.
Boxer Capital Management first reported a position in GOSS in Q1 2019 and held it in 19 quarters. The position peaked at $42.8M in Q3 2022. 96 funds tracked by Wall St. Rank hold GOSS as of Q4 2023.
- Boxer Capital Management reported no remaining Gossamer Bio position as of Q4 2023 after selling out during the quarter.
- Boxer Capital Management sold 81,221 Gossamer Bio shares in Q4 2023, an estimated $5.41M.
- Boxer Capital Management first reported a position in Gossamer Bio in Q1 2019 and held it in 19 quarters.
- Boxer Capital Management's Gossamer Bio position peaked at $42.8M in Q3 2022.
- 96 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2023.
Based on Boxer Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.